ACETYL LEUCINE FOR USE IN THE TREATMENT OF NIEMANN-PICK DISEASE TYPE C
MX2025011968APending Publication Date: 2026-05-04INTRABIO INC
Patent Information
- Authority / Receiving Office
- MX · MX
- Patent Type
- Applications
- Current Assignee / Owner
- INTRABIO INC
- Filing Date
- 2025-10-06
- Publication Date
- 2026-05-04
Abstract
This disclosure provides methods for treating NPC, or a neurological symptom thereof, in a subject by administering a therapeutically effective amount of N-acetyl leucine, wherein the subject has one or more NPC1 mutations.
Need to check novelty before this filing date? Find Prior Art